Clinical Trial Update: Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders [Phase 3]

View source ↗

Summary

An ongoing Phase 3 trial compares weekly lonapegsomatropin to daily somatropin in children and adolescents with short stature due to growth hormone–sufficient d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature
• Shox-related Short Stature
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• Skytrofa (lonapegsomatropin)
• Somatropin (somatropin)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Turner Syndrome, Short Stature Homeobox Gene Mutation | Phase 3 | Status: RECRUITING